The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdams Regulatory News (ADA)

Share Price Information for Adams (ADA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 5.00
Ask: 8.00
Change: 0.00 (0.00%)
Spread: 3.00 (60.00%)
Open: 6.50
High: 6.50
Low: 6.50
Prev. Close: 6.50
ADA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Open Offer

15 Apr 2021 12:48

RNS Number : 6253V
Adams PLC
15 April 2021
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 ("MAR") AND THE RETAINED UK LAW VERSION OF MAR PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019 (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA THE REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

All of the defined terms in this announcement have the same meaning as in the circular published by the Company and sent to Shareholders on 26 March 2021.

 

15 April 2021

 

 

 

Adams plc

("Adams" or the "Company")

 

 

Result of Open Offer

 

 

Open Offer

Adams is pleased to confirm that it has received valid applications in respect of 54,655,999 Open Offer Shares raising £3,552,640 for the Company (before expenses), pursuant to the Open Offer announced on 26 March 2021. Qualifying Shareholders who validly applied for Open Offer Shares pursuant to their Open Offer Entitlement will receive the full amount of Open Offer Shares applied for. The applications included an application by Richard Griffiths for 47,872,535 Open Offer Shares and an application by David Richardson for 6,018,185 Open Offer Shares.

 

Application has been made for the admission of the 54,655,999 Open Offer Shares to trading on AIM, with Admission expected to become effective at 8.00 a.m. on 21 April 2021. The Open Offer Shares will, when issued and fully paid, rank pari passu in all respects with the Existing Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid after the date of Admission.

 

 

Substantial Shareholder

Following Admission, Richard Griffiths and David Richardson will have the following interests in the Ordinary Shares in the Company:

 

Name

Number of Ordinary Shares

% of Issued Share Capital

Richard Griffiths

111,702,582

76.58

David Richardson

14,042,432

9.63

 

 

 

Directors Holdings

 

The Directors' interests in the Ordinary Shares in the Company following completion of the Placing and Open Offer are as follows:

 

Director

Interest in Ordinary Shares

% of Enlarged Share Capital

after Open Offer Admission

Michael Bretherton

1,385,000

0.95

Andrew Mitchell

308,000

0.21

Nicholas Woolard

0

0

 

 

Total voting rights

Following Admission, the number of Ordinary Shares in issue will be 145,859,231. For the purposes of the Disclosure Guidance and Transparency Rules, the total number of voting rights in the Company with effect from 21 April 2021 will be 145,859,231. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company, under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Enquiries:

 

 

Adams plc

 

Mike Bretherton

Tel: +44 1534 719761

Nomad - Cairn Financial Advisers LLP

 

Sandy Jamieson, James Caithie

Tel: +44 207 213 0880

Broker - Peterhouse Capital Limited

 

Heena Karani/Duncan Vasey

Tel: +44 207 469 0933

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPEAFLSFLLFEFA
Date   Source Headline
20th Dec 202310:15 amRNSHolding(s) in Company
23rd Nov 20237:00 amRNSHalf-year Report
26th Sep 20234:03 pmRNSHolding(s) in Company
18th Aug 20233:33 pmRNSResult of AGM
16th Aug 20231:04 pmRNSHolding(s) in Company
15th Aug 20233:37 pmRNSHolding(s) in Company
14th Jul 20237:00 amRNSFinal Results
9th Mar 20233:47 pmRNSAnnouncement by WANdisco
18th Jan 202312:00 pmRNSHolding(s) in Company
17th Jan 20234:18 pmRNSHolding(s) in Company
24th Nov 20227:00 amRNSHalf-year Report
26th Aug 20223:44 pmRNSResult of AGM
7th Jul 20227:00 amRNSFinal Results
26th Nov 20217:00 amRNSHalf-year Report
26th Aug 202111:29 amRNSResult of AGM
28th Jun 20217:00 amRNSFinal Results
27th May 20217:00 amRNSInvestment in Motif Bio Plc
7th May 202111:33 amRNSHolding(s) in Company
7th May 202111:30 amRNSHolding(s) in Company
7th May 20217:00 amRNSInvestment in Seeing Machines Limited
15th Apr 202112:48 pmRNSResult of Open Offer
26th Mar 20217:00 amRNSPlacing and Open Offer
26th Nov 20207:00 amRNSHalf-year Report
22nd Oct 202010:23 amRNSInvestment Commitment in C4X Discovery Holdings
21st Aug 202012:45 pmRNSResult of AGM
30th Jun 20207:00 amRNSFinal Results
19th Jun 20203:24 pmRNSAssignment of Shareholder Loan Facility
12th Jun 20204:41 pmRNSSecond Price Monitoring Extn
12th Jun 20204:36 pmRNSPrice Monitoring Extension
10th Jun 20207:00 amRNSInvestment
19th Mar 20203:41 pmRNSStatement re COVID-19
11th Mar 20209:41 amRNSChange of Registered Office
3rd Jan 20207:00 amRNSInvestment
17th Dec 20198:57 amRNSDisposal
28th Nov 20197:00 amRNSHalf-year Report
9th Aug 201911:59 amRNSResult of AGM
3rd Jul 20197:00 amRNSFinal Results
29th Jan 20191:26 pmRNSShareholder Loan
27th Nov 20187:00 amRNSHalf-year Report
10th Aug 20182:01 pmRNSResult of AGM
26th Jun 20187:03 amRNSChange of Currency and AGM Proposals
26th Jun 20187:00 amRNSFinal Results
4th Jun 20189:56 amRNSHolding(s) in Company
4th Jun 20189:48 amRNSHolding(s) in Company
15th Dec 201712:55 pmRNSInvestment
28th Nov 20177:00 amRNSHalf-year Report
27th Nov 20172:07 pmRNSInvestment
6th Oct 201712:28 pmRNSDisposal
11th Sep 20175:06 pmRNSInvestment
8th Sep 20175:04 pmRNSResult of AGM and EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.